Metastatic Fibrolamellar Hepatocellular Carcinoma to the Pancreas.
Fibrolamellar hepatocellular carcinoma (FL-HCC) is a rare variant of hepatocellular carcinoma, usually presenting in the younger population (<40 years) without underlying liver disease. Although it has a better prognosis than hepatocellular carcinoma, it has a high rate of recurrence months to years after primary resection. While sites of recurrence usually involve the liver, regional lymph nodes, peritoneum, and lung, metastasis to the pancreas is extremely rare, with only 2 other cases reported in the literature. We present the case of a 46-year-old patient with metastatic FL-HCC to the pancreas 30 years after diagnosis and 26 years since his last resected liver recurrence.
Division of Gastroenterology and Hepatology, Scottsdale, Ariz., USA.
Nicolas A
NA
Villa
Division of Gastroenterology and Hepatology, Scottsdale, Ariz., USA.
Rahul
R
Pannala
Division of Gastroenterology and Hepatology, Scottsdale, Ariz., USA.
Douglas O
DO
Faigel
Department of General Surgery, Mayo Clinic Arizona, Scottsdale, Ariz., USA.
Danielle J
DJ
Haakinson
Division of Transplant Surgery, Mayo Clinic Arizona, Scottsdale, Ariz., UAS.
Nitin
N
Katariya
Division of Hematology and Oncology, Mayo Clinic Arizona, Scottsdale, Ariz., USA.
Ramesh
R
Ramanathan
Division of Cardiothoracic Surgery, Mayo Clinic Arizona, Scottsdale, Ariz., USA.
Dawn
D
Jaroszewski
Department of Pathology, Mayo Clinic Arizona, Scottsdale, Ariz., USA.
Thomas K
TK
Lidner
Division of Gastroenterology and Hepatology, Scottsdale, Ariz., USA.
Thomas
T
Byrne
Fibrolamellar hepatocellular carcinoma; Liver transplantation; Metastasis